Itraconazole and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Itraconazole (itraconazole), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Prednisolone, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Itraconazole. It is created by eHealthMe based on reports of 12,233 people who have side effects when taking Itraconazole from the FDA, and is updated regularly.

What is Itraconazole?

Itraconazole has active ingredients of itraconazole. It is often used in fungal infection. eHealthMe is studying from 12,372 Itraconazole users. Check the latest studies of Itraconazole.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,807 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

On Jul, 12, 2026

12,233 people reported to have side effects when taking Itraconazole.
Among them, 20 people (0.16%) have Chronic obstructive pulmonary disease.

Could Itraconazole cause Chronic obstructive pulmonary disease?

Among these 20 people:

How long have people been on Itraconazole when they have Chronic obstructive pulmonary disease? *

What is the gender of people who have Chronic obstructive pulmonary disease when taking Itraconazole? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Itraconazole? *

What are other drugs people take besides Itraconazole? *

What are other side effects people have besides Chronic obstructive pulmonary disease? *

Diabetes: 9 people, 45.00%
Skin Blushing/flushing (a sudden reddening of the face, neck): 7 people, 35.00%
Fever: 7 people, 35.00%
Dehydration (dryness resulting from the removal of water): 7 people, 35.00%
Hyperkalemia (damage to or disease of the kidney): 7 people, 35.00%
Hypotension (abnormally low blood pressure): 7 people, 35.00%
Pneumonia: 7 people, 35.00%
Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 20.00%
Brain Natriuretic Peptide Increased: 3 people, 15.00%
Urinary Tract Infection: 2 people, 10.00%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 50.00%
Diabetes: 6 people, 30.00%
Hyperkalemia (damage to or disease of the kidney): 4 people, 20.00%
Pneumonia: 2 people, 10.00%
Stress And Anxiety: 1 person, 5.00%
Osteoporosis (bones weak and more likely to break): 1 person, 5.00%
Neutrophil Function Disorder (impairment in neutrophil responses that are critical for host defence): 1 person, 5.00%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.00%
Hepatitis C: 1 person, 5.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Itraconazole and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Itraconazole:

Itraconazole (12,372 reports)

Browse all side effects of Itraconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (1,807 drugs)

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on itraconazole (the active ingredients of Itraconazole) and Itraconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.